Related references
Note: Only part of the references are listed.Emerging roles of aerobic glycolysis in breast cancer
Z. Wu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Synthesis of novel 7-azaindole derivatives containing pyridin-3-ylmethyl dithiocarbamate moiety as potent PKM2 activators and PKM2 nucleus translocation inhibitors
Bin Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Structure-activity relationships of novel dithiocarbamates containing α,β-unsaturated ketone fragment as potent anticancer agents
Yuanqiang Wang et al.
MEDICINAL CHEMISTRY RESEARCH (2019)
An overview of structure, function, and regulation of pyruvate kinases
Norbert Schormann et al.
PROTEIN SCIENCE (2019)
Pyruvate kinase M2: A simple molecule with complex functions
Mohammed Alquraishi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activators
Ridong Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
PKM2, a potential target for regulating cancer
Yu-huan Li et al.
GENE (2018)
Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia
Jing Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
Ming-Chuan Hsu et al.
MOLECULAR CANCER (2018)
PKM2, cancer metabolism, and the road ahead
Talya L. Dayton et al.
EMBO REPORTS (2016)
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds
Yu Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents
Ri-Dong Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Novel Pyruvate Kinase M2 Activator Compound that Suppresses Lung Cancer Cell Viability under Hypoxia
Dong Joon Kim et al.
MOLECULES AND CELLS (2015)
Nuclear PKM2 contributes to gefitinib resistance via upregulation of STAT3 activation in colorectal cancer
Qiong Li et al.
SCIENTIFIC REPORTS (2015)
Novel Dithiocarbamic Acid Esters Derived from 6-Aminomethyl-4-anilinoquinazolines and 6-Aminomethyl-4-anilino-3-cyanoquinolines as Potent EGFR Inhibitors
Xin Zhang et al.
ARCHIV DER PHARMAZIE (2013)
PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells
William J. Israelsen et al.
CELL (2013)
Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States
Dan Y. Gui et al.
SCIENCE SIGNALING (2013)
1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase
Avihai Yacovan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Small Molecule Activation of PKM2 in Cancer Cells Induces Serine Auxotrophy
Charles Kung et al.
CHEMISTRY & BIOLOGY (2012)
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Xueliang Gao et al.
MOLECULAR CELL (2012)
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Weiwei Yang et al.
NATURE CELL BIOLOGY (2012)
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Dimitrios Anastasiou et al.
NATURE CHEMICAL BIOLOGY (2012)
SAICAR Stimulates Pyruvate Kinase Isoform M2 and Promotes Cancer Cell Survival in Glucose-Limited Conditions
Kirstie E. Keller et al.
SCIENCE (2012)
Novel EGFR inhibitors prepared by combination of dithiocarbamic acid esters and 4-anilinoquinazolines
Ri-Dong Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase
Martin J. Walsh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase
Jian-kang Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Evaluation of Substituted N,N′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase
Matthew B. Boxer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Dithiocarbamic acid esters as anticancer agent. Part 1: 4-substituted-piperazine-1-carbodithioic acid 3-cyano-3,3-diphenyl-propyl esters
Xueling Hou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Share Paper
